J. Ruiz

发表

Phenotyping is an accurate means of analysing the principal apolipoprotein E isoforms.

P. Froguel, H. Blanché, P. Passa, 1994, Clinica chimica acta; international journal of clinical chemistry.

Additive effect of A-->G (-3826) variant of the uncoupling protein gene and the Trp64Arg mutation of the beta 3-adrenergic receptor gene on weight gain in morbid obesity.

K. Clément, B. Guy-grand, A. Cassard-Doulcier, 1996, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

Association of poorly controlled diabetes with low serum leptin in morbid obesity

K. Clément, P. Froguel, B. Guy-grand, 1997, International Journal of Obesity.

The (Ala-Val) mutation of methylenetetrahydrofolate reductase as a genetic risk factor for vascular disease in non-insulin-dependent diabetic patients.

P. Froguel, P. Passa, R. James, 1997, American journal of human genetics.

Association of elevated lipoprotein(a) levels and coronary heart disease in NIDDM patients. Relationship with apolipoprotein(a) phenotypes

P. Froguel, P. Passa, D. Erlich, 1994, Diabetologia.

Paraoxonase polymorphism in non-insulin dependent diabetes: A link between lipid oxidation and coronary heart disease

P. Froguel, H. Blanché, P. Passa, 1995 .

The relationship between paraoxonase polymorphism and plasma lipids/lipoproteins in non-insulin dependent diabetes

P. Froguel, H. Blanché, P. Passa, 1995 .

Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus.

F. Cambien, P. Froguel, H. Blanché, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes

G. Charpentier, P. Froguel, H. Blanché, 1995, The Lancet.

Genetic Variation in the β3-Adrenergic Receptor and an Increased Capacity to Gain Weight in Patients with Morbid Obesity

K. Clément, K. Silver, P. Froguel, 1995 .

Mutation screening of the PPARalpha gene in type 2 diabetes associated with coronary heart disease.

G. Charpentier, P. Froguel, B. Staels, 2000, Diabetes & metabolism.

Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity.

K. Clément, K. Silver, A. Shuldiner, 1995, The New England journal of medicine.

Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes.

P. Froguel, H. Blanché, P. Passa, 1997, The Journal of clinical investigation.

The adiponectin gene SNP+45 is associated with coronary artery disease in Type 2 (non‐insulin‐dependent) diabetes mellitus

C. Dina, P. Froguel, S. Lobbens, 2004, Diabetic medicine : a journal of the British Diabetic Association.

Mutation screening of the PPAR agene in type 2 diabetes associated with coronary heart disease

G. Charpentier, P. Froguel, B. Staels, 2008 .

Promoter polymorphism T(-107)C of the paraoxonase PON1 gene is a risk factor for coronary heart disease in type 2 diabetic patients.

P. Froguel, P. Passa, I. Leviev, 2000, Diabetes.